Patients at increased risk of polymicrobial and MRSA infection
For mild infection of diabetes-related foot ulcers in patients at increased risk of polymicrobial infection (see Antibiotic choice for mild infection of diabetes-related foot ulcers) and increased risk of MRSA infection, a regimen containing trimethoprim+sulfamethoxazole may be an option. However, trimethoprim+sulfamethoxazole is associated with an increased risk of acute kidney injury and hyperkalaemia in patients with diabetesFraser, 2012. If trimethoprim+sulfamethoxazole is used, measure serum creatinine and potassium concentrations before starting treatment, and repeat within7 days of starting treatmentRajput, 2020. A suitable 2-drug regimen is:
trimethoprim+sulfamethoxazole 160+800 mg orally, 12-hourly. For dosage adjustment in adults with kidney impairment, see trimethoprim+sulfamethoxazole dosage adjustment. See advice on duration of therapy trimethoprim + sulfamethoxazole trimethoprim+sulfamethoxazole trimethoprim+sulfamethoxazole
PLUS
metronidazole 400 mg orally, 12-hourly. See advice on duration of therapy. metronidazole metronidazole metronidazole
For patients who cannot tolerate trimethoprim+sulfamethoxazole, seek expert advice.
Modify therapy based on the results of culture and susceptibility testing.